Ben Morris
Impact in
- Physiology top 10%
- Telomeres, Telomerase, and Senescence
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- DNA Repair Mechanisms 5
- Epigenetics and DNA Methylation 2
- Protein Degradation and Inhibitors 2
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 4
- Cancer Cells and Metastasis 2
- Co-authors
- Roderick L. Beijersbergen (12 shared papers)Cor Lieftink (10 shared papers)Rodrigo Leite de Oliveira (2 shared papers)Fleur Jochems (2 shared papers)René Bernards (2 shared papers)Cun Wang (1 shared paper)Sara Mainardi (1 shared paper)Bastiaan Evers (1 shared paper)
- Journals
- Nature Communications (2 papers)Cell Reports Medicine (2 papers)Cell Reports (2 papers)Nucleic Acids Research (2 papers)Life Science Alliance (1 paper)
- Partner nations
- NetherlandsChinaUnited States
In The Last Decade
Ben Morris
19 papers receiving 978 citations
Ben Morris's Hit Papers
Peers
Comparison fields: 5 of 63
- Physiology 277
- Hepatology 63
- Oncology 152
- Aging 11
- Cancer Research 79
Countries citing papers authored by Ben Morris
This map shows the geographic impact of Ben Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Morris more than expected).
Fields of papers citing papers by Ben Morris
This network shows the impact of papers produced by Ben Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Morris. The network helps show where Ben Morris may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inducing and exploiting vulnerabilities for the treatment of liver cancer Hit paper breakdown → | 2019 | 351 |
| 2 | 2017 | 190 | |
| 3 | 2021 | 134 | |
| 4 | 2021 | 60 | |
| 5 | 2024 | 37 | |
| 6 | 2018 | 34 | |
| 7 | 2023 | 31 | |
| 8 | 2017 | 28 | |
| 9 | 2024 | 26 | |
| 10 | 2019 | 19 | |
| 11 | 2024 | 15 | |
| 12 | 2023 | 14 | |
| 13 | 2022 | 11 | |
| 14 | 2022 | 9 | |
| 15 | 2024 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2025 | 7 | |
| 18 | 2025 | 5 | |
| 19 | 2025 | 1 | |
| 20 | 2024 | 0 |
About Ben Morris
Ben Morris is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Immunology, having authored 20 papers that have together received 989 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Epigenetics and DNA Methylation (2 papers), Cancer Cells and Metastasis (2 papers), Protein Degradation and Inhibitors (2 papers), Prostate Cancer Treatment and Research (2 papers), Telomeres, Telomerase, and Senescence (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Physiology (277 citations), Hepatology (63 citations), Oncology (152 citations), Aging (11 citations) and Cancer Research (79 citations). Ben Morris has collaborated with scholars based in Netherlands, China and United States. Frequent co-authors include Roderick L. Beijersbergen, Cor Lieftink, Rodrigo Leite de Oliveira, Fleur Jochems, René Bernards, Cun Wang, Sara Mainardi, Bastiaan Evers, Lisa Willemsen and Liqin Wang. Their work appears in journals such as Nature Communications, Cell Reports Medicine, Cell Reports, Nucleic Acids Research and Life Science Alliance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.